All categories
Science8 feeds
BioPharm International articles(biopharminternational.com)
<![CDATA[The Biopharm Brief: Microbiome Fast Track, Leo Pharma Gene Therapy Deal, AAV Automation Advances]]><![CDATA[Restore Vision Reports Early Clinical Signal for GPCR-Based Optogenetic Therapy in Retinitis Pigmentosa]]><![CDATA[Ensorcell Debuts VersaWeld Platform, Wins Best New Product at INTERPHEX 2026]]><![CDATA[Microbiome-Based Therapy Gains FDA Fast Track in Ulcerative Colitis ]]><![CDATA[LEO Pharma Expands Rare Dermatology Pipeline with Replay Gene Therapy Acquisition]]><![CDATA[How Automation Is Improving AAV Purification for Gene Therapy Development ]]><![CDATA[The BioPharm Brief: Metabolic Phase III Progress, HER2 Oncology Momentum, and US Manufacturing Expansion Drive Industry Scale]]>
Biotech / Medtech Archives | citybiz(citybiz.co)
Medcura Appoints Medical Device Veteran Gary P. Fischetti to Board of DirectorsGreen Boy Leads Early-Stage Investment in Fudi Protein to Advance RuBisCO-Based Plant Protein Scale-UpVentric Health Adds Leading Cardiologists to Clinical Advisory Board as It Expands Adoption of Vivio® SystemSpecialty Nutrition Appoints Alejandra Gratson as Managing Partner to Strengthen Innovation and Commercialization StrategyRadiology Partners Adds Former Maryland Governor Larry Hogan to BoardMade Scientific Expands Board of Directors to Support Cell Therapy Manufacturing Scale-UpPeer-Reviewed Study in Journal of Diabetes Research Verifies Glucotrack’s Long‑Term Continuous Blood Glucose Monitoring Technology
DNA-Containing Extracellular Vesicles Boost Antitumor Responses in MiceRestoring Protein Recycling Reverses T-Cell Exhaustion in MiceFigurate SCADA System Launched to Overcome Digital Bottlenecks During Biopharma ManufacturingApproaches to Reducing Toxicity and Side Effects in Cell and Gene TherapyTop 10 Best Selling Gene TherapiesGoing Non-Viral: Gene Delivery Enters Its Translation EraBreaking Through the Barrier
Podcast: Why HPC is Absolutely Ready for the CloudIndustry Leaders on the Promise & Peril of NSCITim Carroll Joins Cycle Computing, Discusses HPC Cloud FutureUpdate on the HPCG BenchmarkDr. Lorena Barba Talks “Women Who CUDA”Virtual Observatories for Big Scientific DataReal World Performance Gains with CUDA 6
Gene therapy restores immune function to infants with SCID-X1 (X-linked severe combined immunodeficiency)Gene therapy company buyouts are making the newsTargeting solid tumors with natural killer (NK) cellsNobel Prize in Medicine for discovery of cancer immunotherapy via checkpoint inhibitionAlnylam’s patisiran, the first ever FDA- and European Commission-approved RNAi therapeuticNewLink Genetics—new organizational and clinical trial strategy for development of its cancer immunotherapy drug indoximodMIT study finds that the probability of clinical trial success is nearly 40% higher than previously thought
A Reinforcement Learning Approach in Multi-Phase Second-Price Auction Design
Learning Bayesian Network Classifiers to Minimize Class Variable Parameters
skwdro: a library for Wasserstein distributionally robust machine learning
A causal fused lasso for interpretable heterogeneous treatment effects estimation
DCatalyst: A Unified Accelerated Framework for Decentralized Optimization
Exploring Novel Uncertainty Quantification through Forward Intensity Function Modeling
Error Analysis for Deep ReLU Feedforward Density-Ratio Estimation with Bregman Divergence
Earendil Labs Gets $787M to Push AI-Designed Antibodies Toward the ClinicAI-Guided Brain Implant for Memory Loss Gets FDA Breakthrough StatusMerck Signs $20M Deal With Quotient to Find IBD Targets Using Somatic GenomicsAnthropic Pays $400M for an AI Biotech With Fewer Than Ten PeopleNovo Nordisk and OpenAI Team Up to Integrate AI from Discovery to Supply ChainTwo Ex-GSK AI Leads Go Stealth with a New Oncology Drug Discovery StartupJeito Closes €1B Fund, Europe's Largest Independent Biopharma Raise
Thinning revenues: inside the $14bn Eliquis patent cliffChiesi widens rare disease portfolio with $1.9bn KalVista buyoutTeva signs off $900m Emalex buyout amid strategic pipeline boosting ployEU’s Joint Clinical Assessment system still finding its footingHow eSource adoption is saving time and costs in clinical researchRay Therapeutics receives EMA PRIME status for gene therapyRegeneron Q1 2026 net income falls 10% to $727m
